Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study

European Radiology

Volumn 19, Issue 1, 2009, Pages 79-89

  Goh, Vicky ^a   Halligan, Steve ^b   Wellsted, David M ^c   Bartram, Clive I ^d  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^d ST MARK S HOSPITAL   (United Kingdom)

Author keywords

Cancer, colon; Cancer, rectum; Dynamic CT; Perfusion CT

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE INTERVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS POTENTIAL; ORGAN PERFUSION; PILOT STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TUMOR VASCULARIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 59249106620     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-008-1128-1     Document Type: Article

References (56)

1. McArdle CS, Hole D, Hansell D et al (1990) Prospective study of colorectal cancer in the west of Scotland: 10-year follow-up. Br J Surg 77:280-282
2. Sargent DJ, Waiend HS, Haller DG et al (2005) Disease-free survival versus overall survival as a primary end point for adjuvant colon studies: Individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 23:8664-8670
3. Sargent DJ, Patiyil S, Yothers G et al (2007) End points for colon cancer adjuvant trials: Observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT group. J Clin Oncol 25:4569-4574
4. Punt CJ (2004) New options and old dilemmas in the treatment of patients with advanced colorectal cancer. Ann Oncol 15:1453-1459
5. Goldberg RM, Hurwitz HI, Fuchs CS (2006) The role of targeted therapy in the treatment of colorectal cancer. Clin Adv Hematol Oncol 4(8 Supl 17):1-10
6. Ogura O, Takebayashi Y, Sameshima T et al (2001) Pre-operative assessment of vascularity by color Doppler ultrasonography in human rectal carcinoma. Dis Colon Rectum 44:538-548
7. Chen CN, Cheng YM, Liang JT et al (2000) Color Doppler vascularity index can predict distant metastasis and survival in colon cancer patients. Cancer Res 60:2892-2897
8. Leen E, Angerson WJ, Wotherspoon H et al (1995) Detection of colorectal liver metastases: Comparison of laparotomy, CT, US, and Doppler perfusion index and evaluation of postoperative follow-up results. Radiology 195:113-116
9. Leen E, Goldberg JA, Angerson WJ et al (2000) Potential role of doppler perfusion index in selection of patients with colorectal cancer for adjuvant chemotherapy. Lancet 355:34-37
10. Fowler RC, Harris KM, Swift SE et al (1998) Doppler perfusion index: measurement in nine healthy volunteers. Radiology 209:867-871
11. Willett CG, Boucher Y, Di Tomaso E et al (2004) Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 10:145-147
12. Meijerink MR, Van Cruijsen H, Hoekman K et al (2007) The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients. Eur Radiol 17:1700-1713
13. Ng QS, Goh V, Milner J et al (2007) Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: A phase I study. Lancet Oncol 8:111-118
14. Ng QS, Goh V, Carnell D et al (2007) Tumor antivascular effects of radiotherapy combined with combretastatin a4 phosphate in human non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 67:1375-1380
15. Tateishi U, Kusumoto M, Nishihara H, Nagashima K, Morikawa T, Moriyama N (2002) Contrast enhanced dynamic computed tomography for the evaluation of angiogenesis in patients with lung carcinoma. Cancer 95:835-842
16. Wang JH, Min PQ, Wang PJ et al (2006) Dynamic CT evaluation of tumor vascularity in renal cell carcinoma. AJR Am J Roentgenol 186:1423-1430
17. Purdie TG, Henderson E, Lee TY (2001) Functional CT imaging of angiogenesis in rabbit VX2 soft-tissue tumour. Phys Med Biol 46:3161-3175
18. Goh V, Halligan S, Hugill JA et al (2006) Quantitative assessment of tissue perfusion using MDCT: Comparison of colorectal cancer and skeletal muscle measurement reproducibility. AJR Am J Roentgenol 187:164-169
19. Goh V, Halligan S, Hugill JA et al (2005) Quantitative colorectal cancer perfusion measurements using MDCT: Inter and intra-observer agreement. AJR Am J Roentogenol 185:225-231
20. St Lawrence KS, Lee TY (1998) An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: I. Theoretical derivation. J Cereb Blood Flow Metab 18:1365-1377
21. Moertel CG, Fleming TR, MacDonald JS et al (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352-358
22. Andre T, Boni C, Mounedji-Boudiaf L et al (2004) Oxaliplatin, flurouracil and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343-2351
23. Benson AB 3rd, Schrag D, Somerfield MR et al (2004) American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22:3408-3419
24. Andre T, Sargent D, Tabernero J et al (2006) Current issues in adjuvant treatment of stage II colon cancer. Ann Surg Oncol 13:887-898
25. Efficacy of adjuvant flurouracil and folinic acid in B2 colon cancer (1999) International multicentre pooled analysis of B2 colon cancer trials (IMPACT B2) investigators. J Clin Oncol 17:1356-1363
26. Des Guetz G, Uzzan B, Nicolas P et al (2006) Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br J Cancer 94:1823-1832
27. Werther K, Christensen IJ, Brunner N et al (2000) Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group. Eur J Surg Oncol 26:657-662
28. Cascinu S, Staccioli MP, Gasparini G et al (2000) Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer. Clin Cancer Res 6:2803-2807
29. Vermeulen PB, Van den Eynden GG, Huget P et al (1999) Prospective study of intratumoral microvessel density, p53 expression, and survival in colorectal cancer. Br J Cancer 79:316-322
30. Furudoi A, Tanaka S, Haruma K et al (2002) Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma. Oncology 62:157-166
31. Frank RE, Saclarides TJ, Leurgens S et al (1995) Tumor angiogenesis as predictor of recurrence and survival in patients with node negative colon cancer. Ann Surg 222:695-699
32. Graziano F, Cascinu S (2003) Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: How much evidence is enough? Ann Oncol 14:1026-1038
33. Miles KA, Hayball M, Dixon AK (1991) Colour perfusion imaging: A new application of computed tomography. Lancet 337:643-645
34. Miles KA (1991) Measurement of tissue perfusion by dynamic computed tomography. Br J Radiol 64:409-412
35. Haider MA, Milosevic M, Fyles A et al (2005) Assessment of the tumor microenvironment in cervix cancer using dynamic contrast enhanced CT, interstitial fluid pressure and oxygen measurements. Int J Radiat Oncol Biol Phys 62:1100-1107
36. Graeber TG, Osmanian C, Jacks T et al (1996) Hypoxia mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379:88-91
37. Reynolds TY, Rockwell S, Glazer PM (1996) Genetic instability induced by the tumor microenvironment. Cancer Res 56:5754-5757
38. Hockel M, Schlenger K, Aral B et al (1996) Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56:4509-4515
39. Sundfor K, Lyng H, Rofstad EK (1998) Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. Br J Cancer 78:822-827
40. Brizel DM, Scully SP, Harrelson JM et al (1996) Tumor oxygenation predicts the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56:941-943
41. Hockel M, Vaupel P (2001) Tumor hypoxia: Definitions, and current clinical, biological, and molecular aspects. J Natl Canc Inst 93:266-276
42. Goethals L, Debucquoy A, Perneel C et al (2006) Hypoxia in human colorectal adenocarcinoma: Comparison between extrinsic and potential intrinsic hypoxia markers. Int J Radiation Oncology Biol Phys 65:246-254
43. Shweiki D, Itin A, Soffer D et al (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia initiated angiogenesis. Nature 359:843-845
44. Yao K, Gietama JA, Shida S et al (2005) In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo. Br J Cancer 93:1356-1363
45. Sahani DV, Kalva SP, Hamberg LM et al (2005) Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: Initial observations. Radiology 234:785-792
46. Bellomi M, Petralia G, Sonzogni A, Zampino MG, Rocca A (2007) CT perfusion for the monitoring of neo-adjuvant chemoradiation therapy in rectal carcinoma. Radiology 244:486-493
47. Hermans R, Meijerink M, Van den Bogaert W et al (2003) Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head and neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys 57:1351-1356
48. Mooteri S, Rubin D, Leurgans S et al (1996) Tumor angiogenesis in primary and metastatic colorectal cancers. Dis Colon Rectum 39:1073-1080
49. Berney CR, Yang YL, Fisher RJ et al (1998) Vascular endothelial growth factor expression is reduced in liver metastasis from colorectal cancer and correlates with urokinase-type plasminogen activator. Anticancer Res 18:973-977
50. De Lussanet QG, Backes WH, Griffioen AW et al (2005) Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer. Int J Radiat Oncol Biol 63:1309-1315
51. DeVries AF, Griebel J, Kremser C et al (2001) Tumor microcirculation evaluated by dynamic contrast enhanced magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. Cancer Res 61:2513-2516
52. De Vries A, Griebel J, Kremser C et al (2000) Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: Preliminary results and implications for therapy. Radiology 217:385-391
53. Altman DG, Royston P (2000) What do we mean by validating a prognostic model? Stat Med 53:219-221
54. Goh V, Halligan S, Bartram CI (2007) Quantitative tumor perfusion assessment using MDCT: Are measurements from two different commercial software packages interchangeable? Radiology 242:777-782
55. Ng QS, Goh V, Fichte H et al (2006) Lung cancer perfusion at multidetector row CT: Reproducibility of whole tumor quantitative measurements. Radiology 239:547-553
56. Ng QS, Goh V, Klotz E et al (2006) Quantitative assessment of lung cancer perfusion using MDCT:dOes measurement reproducibility improve with greater tumor volume coverage? AJR Am J Roentgenol 187:1079-1084